Possible Skin Cancer Vaccine Shows Promise In Late Stage Trial. Moderna Stock Skyrockets.

Fonte: International Business Times

Moderna announces positive results on groundbreaking cancer treatment. Reuters News of a potential personalized cancer vaccine more than doubled the value of Moderna's stock Wednesday. Moderna and Merck jointly announced Wednesday that a late-stage trial produced positive results, CNBC reported.